Human Immunoglobulin (pH4) for Intravenous Injection Market Growth Accelerated by High Adoption of Subcutaneous Immunoglobulin Therapy Products



 Human immunoglobulin plays a key role in fighting bacterial infections and providing immune support for those with certain health conditions. The market for these products has grown significantly, driven by the increased use of subcutaneous immunoglobulin therapy for patients with primary immunodeficiencies. Subcutaneous administration allows for self-administered infusions at home rather than intravenous administration in clinics or hospitals.

The global Human Immunoglobulin (pH4) for Intravenous Injection Market is estimated to be valued at US$ 25.6 billion in 2023 and is expected to exhibit a CAGR of 16.% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The key trend accelerating growth in the human immunoglobulin (pH4) for intravenous injection market is the rising preference for subcutaneous immunoglobulin therapy. Compared to intravenous administration, subcutaneous infusion allows patients to administer immunoglobulin treatment themselves at home on a regular basis. This provides several advantages such as reduced infections risks, fewer systemic side effects, and improved quality of life and independence for patients. As subcutaneous therapy products gain awareness, their demand is rising globally which is positively impacting the overall immunoglobulin market. Manufacturers are increasingly focusing on the development of concentrated, ready-to-use subcutaneous immunoglobulin formulations to tap the opportunities in the space.

Segment Analysis
The global human immunoglobulin (pH4) for intravenous injection market is dominated by the liquid sub-segment owing to its ease of use and administration. The liquid sub-segment accounts for around 70% of the total market share currently as it can be easily injected intravenously into veins. The liquid form of immunoglobulin is widely adopted for treating various immune system disorders and neurological conditions.

Key Takeaways
The global human immunoglobulin (pH4) for intravenous injection market is expected to witness high growth over the forecast period.

Regional analysis: North America currently dominates the global market owing to growing prevalence of congenital immunodeficiency disorders and rising plasma collection in the region. The presence of major players in the US and Canada and high healthcare expenditure is also driving the North American market. Europe is the second largest market and is expected to grow at a significant rate over the coming years.

Key players: Key players operating in the human immunoglobulin (pH4) for intravenous injection market are CSL Behring, Grifols, Octapharma, Kedrion Biopharma Inc., Takeda, and Bio Products Laboratory. CSL Behring and Grifols together account for around 50% share of the total market owing to their well-established plasma collection and production facilities globally.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Exploring the Frontiers of Healthcare: In Vitro Diagnostics (IVD)

Image
  In today's era of cutting-edge medical technology, the field of diagnostics plays a pivotal role in healthcare. Among the various diagnostic methods available, in vitro diagnostics (IVD) stands out as a cornerstone of modern medicine. IVD encompasses a wide range of tests performed on bodily fluids or tissue samples outside the body, providing valuable insights into a patient's health status and aiding in the diagnosis, treatment, and monitoring of diseases. From routine screenings to complex molecular analyses, IVD has revolutionized medical practice, paving the way for personalized and precise healthcare interventions. Understanding In Vitro Diagnostics : In vitro, Latin for "in glass," denotes tests conducted in a controlled laboratory setting, outside the living organism. In the context of diagnostics, this involves analyzing biological specimens such as blood, urine, saliva, and tissue samples collected from patients. IVD techniques utilize various analytical m...
Read more